Transaction DateRecipientSharesTypePriceValue
18th September 2020Venture Investments, Llc Alexandria38,461Open or private purchase$13.00$499,993.00
18th September 2020Venture Investments, Llc Alexandria1,268,795Conversion of derivative$0.00
15th September 2020Advisors Llc Orbimed4,822,960Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed902,885Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed292,607Grant/award etc.$0.00
25th August 2020Venture Investments, Llc Alexandria467,932Conversion of derivative$0.00
18th August 2020Chau Quang Khuong43,543Open or private sale$108.54$4,726,157.22
18th August 2020Advisors Llc Orbimed43,543Open or private sale$108.54$4,726,157.22
17th August 2020Chau Quang Khuong94,900Open or private sale$107.49$10,200,801.00
17th August 2020Advisors Llc Orbimed94,900Open or private sale$107.49$10,200,801.00
Next Cure
Next Cure logo

NextCure, Inc. is a clinical-stage biopharmaceutical company. It is developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function.

Ticker: NXTC
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1661059
Employees: 44
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags